bf/NASDAQ:EXAS_icon.jpeg

COM:EXACTSCIENCES

Exact Sciences Corp

  • Stock

Last Close

52.70

21/11 21:00

Market Cap

8.36B

Beta: -

Volume Today

2.37M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
2.01M
-
5.35M
166.22%
6.75M
26.33%
16.43M
143.23%
32.59M
98.34%
50.44M
54.77%
76.99M
52.66%
98.63M
28.10%
111.63M
13.18%
122.87M
10.07%
average payables
2.21M
-
1.70M
22.77%
2.98M
74.74%
2.01M
32.53%
8.42M
319.24%
22.14M
162.84%
27.06M
22.22%
30.84M
13.99%
51.77M
67.86%
71.37M
37.87%
76.87M
7.70%
average receivables
688K
-
3.15M
358.50%
6.73M
113.33%
17.47M
159.64%
35.33M
102.20%
87.45M
147.54%
181.93M
108.03%
224.91M
23.63%
187.34M
16.70%
180.83M
3.48%
book value per share
2.00
-
3.60
79.65%
3.55
1.51%
3.28
7.64%
4.50
37.30%
5.57
23.86%
17.43
212.85%
18.68
7.17%
19.77
5.83%
17.26
12.72%
17.46
1.18%
capex per share
-0.14
-
-0.16
13.62%
-0.24
52.70%
-0.15
39.18%
-0.60
312.43%
-1.23
105.99%
-1.31
6.16%
-0.43
67.47%
-0.79
86.09%
-1.22
53.48%
-0.69
43.31%
capex to depreciation
-6.55
-
-3.38
48.38%
-2.84
16.06%
-1.29
54.51%
-4.45
244.96%
-6.53
46.63%
-3.42
47.62%
-0.39
88.48%
-0.75
91.11%
-1.09
44.20%
-0.60
44.63%
capex to operating cash flow
0.24
-
0.15
34.40%
0.16
5.87%
0.11
30.39%
0.97
745.47%
2.17
125.14%
1.49
31.27%
-0.47
131.56%
1.33
381.64%
0.96
27.76%
-0.80
182.92%
capex to revenue
-2.24
-
-6.97
211.30%
-0.56
92.01%
-0.15
73.19%
-0.26
74.19%
-0.33
27.36%
-0.20
40.86%
-0.04
77.99%
-0.08
78.06%
-0.10
33.92%
-0.05
51.72%
cash per share
1.97
-
3.52
78.50%
3.33
5.49%
3.04
8.73%
3.67
20.77%
9.20
150.56%
2.47
73.19%
12.17
393.72%
6.01
50.60%
3.58
40.40%
4.32
20.44%
days of inventory on hand
339.01
-
99.47
70.66%
55.18
44.52%
119.95
117.37%
121.11
0.97%
103.96
14.16%
95.05
8.57%
83.54
12.11%
75.15
10.04%
71.12
5.36%
days payables outstanding
223.39
-
49.28
77.94%
5.73
88.36%
74.36
1,196.87%
87.06
17.07%
43.74
49.75%
36.78
15.91%
53.97
46.71%
47.61
11.79%
43.97
7.63%
days sales outstanding
279.33
-
45.66
83.66%
31.32
31.41%
36.25
15.77%
35.53
1.99%
54.43
53.18%
57.07
4.86%
44.75
21.59%
27.68
38.15%
29.73
7.43%
debt to assets
0.01
-
0.00
62.60%
0.01
215.62%
0.01
7.44%
0.01
41.67%
0.45
5,978.14%
0.27
39.73%
0.35
29.13%
0.36
1.30%
0.39
10.27%
0.39
0.46%
debt to equity
0.01
-
0.00
62.78%
0.02
226.22%
0.01
6.62%
0.01
40.34%
1.01
11,727.62%
0.42
58.74%
0.61
47.00%
0.70
14.60%
0.80
14.35%
0.81
1.02%
dividend yield
0.00
-
0.00
485.55%
0.00
24.05%
0.00
45.31%
0.12
14,261.34%
0.00
-
earnings yield
-0.06
-
-0.05
22.52%
-0.19
308.33%
-0.12
34.09%
-0.02
84.61%
-0.02
20.68%
-0.01
69.54%
-0.04
512.41%
-0.04
5.40%
-0.07
59.89%
-0.02
78.55%
enterprise value
781.55M
-
2.14B
174.38%
814.12M
62.04%
1.32B
62.49%
6.00B
353.91%
8.24B
37.22%
12.91B
56.65%
20.00B
54.92%
15.38B
23.07%
10.94B
28.91%
15.28B
39.70%
enterprise value over ebitda
-16.83
-
-21.33
26.75%
-5.12
76.00%
-7.83
52.93%
-50.75
548.45%
-51.67
1.80%
-59.28
14.73%
-43.01
27.45%
-20.77
51.70%
-22.78
9.64%
-1.16K
5,006.72%
ev to operating cash flow
-19.89
-
-26.50
33.25%
-6.07
77.08%
-10.17
67.43%
-83.72
723.13%
-118.86
41.97%
-112.23
5.57%
146.52
230.55%
-150.47
202.69%
-48.92
67.49%
97.85
300.04%
ev to sales
188.60
-
1.19K
532.39%
20.64
98.27%
13.31
35.51%
22.58
69.59%
18.13
19.69%
14.73
18.76%
13.41
8.97%
8.71
35.08%
5.25
39.73%
6.11
16.48%
free cash flow per share
-0.72
-
-1.16
61.83%
-1.69
45.37%
-1.42
16.36%
-1.22
13.95%
-1.80
47.74%
-2.19
21.38%
0.48
121.84%
-1.39
391.04%
-2.48
78.82%
0.18
107.14%
free cash flow yield
-0.06
-
-0.04
30.70%
-0.18
332.17%
-0.11
42.22%
-0.02
78.12%
-0.03
23.01%
-0.02
17.18%
0.00
115.25%
-0.02
595.44%
-0.05
181.11%
0.00
104.78%
graham net net
1.81
-
3.28
81.53%
3.00
8.51%
2.73
9.09%
3.28
20.22%
2.73
16.70%
-5.83
313.40%
-0.27
95.39%
-11.97
4,358.15%
-13.46
12.42%
-12.94
3.84%
graham number
5.58
-
10.05
80.30%
11.69
16.31%
10.98
6.13%
10.00
8.84%
13.40
33.98%
15.84
18.19%
48.58
206.64%
39.32
19.05%
37.05
5.78%
21.10
43.05%
income quality
0.84
-
0.81
4.27%
0.85
5.01%
0.78
8.41%
0.63
19.40%
0.40
36.87%
1.37
245.95%
-0.16
111.75%
0.17
206.71%
0.36
108.89%
-0.76
313.28%
intangibles to total assets
0
-
0
0
0
0.04
Infinity%
0.03
17.97%
0.67
2,104.30%
0.42
36.72%
0.66
56.44%
0.69
4.27%
0.66
4.78%
interest coverage
-677.70
-
-1.97K
190.89%
-26.51K
1,244.83%
-793.50
97.01%
-574.32
27.62%
-4.33
99.25%
-3.80
12.45%
-5.82
53.28%
-44.90
671.90%
-29.42
34.49%
-8.80
70.07%
interest debt per share
0.03
-
0.02
33.32%
0.05
210.06%
0.05
10.04%
0.04
17.94%
5.94
14,649.58%
7.75
30.44%
12.10
56.20%
14.01
15.81%
13.99
0.17%
14.32
2.37%
inventory turnover
1.08
-
3.67
240.81%
6.61
80.25%
3.04
54.00%
3.01
0.96%
3.51
16.50%
3.84
9.38%
4.37
13.78%
4.86
11.16%
5.13
5.66%
invested capital
0.01
-
0.00
62.78%
0.02
226.22%
0.01
6.62%
0.01
40.34%
1.01
11,727.62%
0.42
58.74%
0.61
47.00%
0.70
14.60%
0.80
14.35%
0.81
1.02%
market cap
793.04M
-
2.20B
177.61%
850.41M
61.37%
1.37B
60.77%
6.08B
344.56%
7.71B
26.87%
12.14B
57.41%
20.02B
64.96%
13.34B
33.40%
8.73B
34.53%
13.33B
52.64%
net current asset value
124.15M
-
269.04M
116.71%
288.69M
7.30%
291.83M
1.09%
409.07M
40.18%
384.99M
5.89%
-660.75M
271.63%
96.99M
114.68%
-1.87B
2,029.06%
-2.20B
17.66%
-2.13B
3.17%
net debt to ebitda
0.25
-
0.57
129.68%
0.23
59.86%
0.26
14.88%
0.62
136.19%
-3.31
635.37%
-3.53
6.59%
0.06
101.65%
-2.76
4,840.91%
-4.59
66.10%
-148.43
3,132.69%
net income per share
-0.69
-
-1.25
80.94%
-1.71
37.35%
-1.63
4.60%
-0.99
39.48%
-1.43
44.93%
-0.64
55.35%
-5.61
777.36%
-3.48
38.08%
-3.54
1.71%
-1.13
67.95%
operating cash flow per share
-0.58
-
-1.01
73.22%
-1.45
44.23%
-1.27
12.62%
-0.62
51.22%
-0.57
8.50%
-0.88
54.46%
0.90
203.06%
-0.60
166.07%
-1.27
112.47%
0.87
168.36%
payables turnover
1.63
-
7.41
353.30%
63.65
759.44%
4.91
92.29%
4.19
14.58%
8.34
99.02%
9.92
18.92%
6.76
31.84%
7.67
13.36%
8.30
8.26%
receivables turnover
1.31
-
7.99
511.82%
11.66
45.80%
10.07
13.62%
10.27
2.03%
6.71
34.72%
6.40
4.63%
8.16
27.53%
13.19
61.69%
12.28
6.91%
research and ddevelopement to revenue
6.68
-
15.94
138.73%
0.86
94.61%
0.34
60.83%
0.16
52.97%
0.15
5.26%
0.16
6.21%
0.37
133.04%
0.22
41.25%
0.19
13.51%
0.17
9.74%
return on tangible assets
-0.32
-
-0.32
1.21%
-0.43
34.92%
-0.44
2.38%
-0.20
55.25%
-0.12
40.28%
-0.07
38.86%
-0.30
312.43%
-0.26
11.64%
-0.32
22.67%
-0.09
71.54%
revenue per share
0.06
-
0.02
63.50%
0.43
1,810.02%
0.97
126.87%
2.30
136.77%
3.72
61.74%
6.68
79.53%
9.87
47.81%
10.31
4.51%
11.82
14.60%
13.88
17.41%
roe
-0.34
-
-0.35
0.72%
-0.48
39.45%
-0.50
3.29%
-0.22
55.92%
-0.26
17.01%
-0.04
85.73%
-0.30
718.67%
-0.18
41.49%
-0.20
16.53%
-0.06
68.32%
roic
-0.33
-
-0.33
0.12%
-0.45
36.35%
-0.46
1.79%
-0.22
51.35%
-0.12
48.54%
-0.02
81.24%
-0.12
444.00%
-0.10
16.04%
-0.10
1.13%
-0.04
63.19%
sales general and administrative to revenue
3.29
-
16.93
413.93%
1.47
91.32%
0.77
47.34%
0.41
47.02%
0.39
4.30%
0.40
2.52%
0.32
19.69%
0.45
40.38%
0.35
21.99%
0.57
60.18%
shareholders equity per share
2.00
-
3.60
79.65%
3.55
1.51%
3.28
7.64%
4.50
37.30%
5.57
23.86%
17.43
212.85%
18.68
7.17%
19.77
5.83%
17.26
12.72%
17.46
1.18%
stock based compensation to revenue
1.87
-
6.41
242.86%
0.46
92.86%
0.24
47.82%
0.13
44.09%
0.13
0.68%
0.12
6.64%
0.10
17.18%
0.14
39.68%
0.10
30.71%
0.09
6.75%
tangible asset value
135.32M
-
288.98M
113.56%
326.86M
13.11%
335.30M
2.58%
498.26M
48.60%
634.66M
27.38%
-58.69M
109.25%
737.39M
1,356.50%
-1.04B
241.30%
-1.26B
20.84%
-1.11B
11.67%
tangible book value per share
2.00
-
3.60
79.65%
3.55
1.51%
3.28
7.64%
4.31
31.46%
5.05
17.29%
-0.45
108.85%
4.88
1,191.23%
-6.08
224.63%
-7.14
17.41%
-6.17
13.53%
working capital
127.71M
-
274.16M
114.68%
299.41M
9.21%
302.88M
1.16%
419.09M
38.37%
1.09B
160.44%
320.46M
70.64%
1.62B
406.37%
909.17M
43.97%
569.51M
37.36%
679.67M
19.34%

All numbers in (except ratios and percentages)